Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.
While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.
Is This 1 Momentum Stock a Screaming Buy Right Now?
Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
Nevro (NVRO)
Headquartered in Menlo Park, CA, Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company’s HF10 therapy provides long-lasting relief from chronic back and leg pain.
NVRO is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of B and VGM Score of B. Shares are up 3.9% over the past one week and up 12.6% over the past four weeks. NVRO has lost 49.2% in the last one-year period as well. Looking at trading volume, an average of 492,808.59 shares exchanged hands over the last 20 trading days.
Momentum investors also pay close attention to a company's earnings. For NVRO, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $2.36 to $0.12 per share for 2022. NVRO boasts an average earnings surprise of 9.2%.
NVRO should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Nevro Corp. (NVRO) : Free Stock Analysis Report
